Mitogen-activated protein kinase inhibitors induce apoptosis and enhance the diallyl disulfide-induced apoptotic effect in human CNE2 cells

Journal of Health Science

Volumn 54, Issue 2, 2008, Pages 129-136

  Wen, Jun ^a   Xiao, Chun Wang ^b   Yi, Wei Zhang ^a   Ya, Li Nie ^a   Talbot, Simon G ^c   Li, Gloria C ^c   Jian, Bo Xiao ^a   Xu, Ming ^a,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Apoptosis; CNE2 cell; Combined effect; Mitogen activated protein kinase inhibitor; Phosphorylation

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; DIALLYL DISULFIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOMA CELL; CELL CYCLE ARREST; CELL GROWTH; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DEPHOSPHORYLATION; ENZYME PHOSPHORYLATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; NASOPHARYNX CARCINOMA;

EID: 44449118419     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.54.129     Document Type: Article

References (52)

1. Wen, J., Zhang, Y. W., Chen, X. Q., Shen, L. B., Li, G. C. and Xu, M. (2004) Enhancement ofdiallyl disulfide-induced apoptosis by inhibitors of MAPKs in human HepG2 hepatoma cells. Biochem. Pharmacol., 68, 323-331.
2. McDaid, H. M. and Horwitz, S. B. (2001) Selective potentiation of paclitaxel (taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines. Mol. Pharmacol., 60, 290-301.
3. Iwai-Kanai, E., Hasegawa, K., Fujita, M., Araki, M., Yanazume, T., Adachi, S. and Sasayama, S. (2002) Basic fibroblast growth factor protects cardiac myocytes from iNOS-mediated apoptosis. J. Cell. Physiol., 190, 54-62.
4. Druesne-Pecollo, N., Pagniez, A., Thomas, M., Cherbuy, C., Duee, P. H., Martel, P. and Chaumontet, C. (2006) Diallyl disulfide increases CDKN1A promoter-associated histone acetylation in human colon tumor cell lines. J. Agric. Food Chem., 54, 7503-7507.
5. Tsai, C. W., Chen, H. W., Yang, J. J., Sheen, L. Y. and Lii, C. K. (2007) Diallyl disulfide and diallyl trisulfide up-regulate the expression of the class of glutathione S-transferase via an AP-1-dependent pathway. J. Agric. Food Chem., 55, 1019-1026.
6. Wang, T. H., Popp, D. M., Wang, H. S., Saitoh, M., Mural, J. G., Henley, D. C., Ichijo, H. and Wimalasena, J. (1999) Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and -independent pathways in ovarian cancer cells. J. Biol. Chem., 274, 8208-8216.
7. Yujiri, T., Fanger, G. R., Garrington, T. P., Schlesinger, T. K., Gibson, S. and Johnson, G. L. (1999) MEK kinase 1 (MEKK1) transduces c-Jun NH2-terminal kinase activation in response to changes in the microtubule cytoskeleton. J. Biol. Chem., 274, 12605-12610.
8. Stone, A. A. and Chambers, T. C. (2000) Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK and p38) signaling pathways in human KB-3 carcinoma cells. Exp. Cell. Res., 254, 110-119.
9. Vinals, F. and Pouyssegur, J. (2001) Transforming growth factor 1 promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-signaling. Mol. Cell. Biol., 21, 7218-7230.
10. Chen, Y.-R., Wang, X., Templeton, D., Davis, R. J. and Tan, T.-H. (1996) The Role of c-Jun N-terminal Kinase (JNK) in Apoptosis Induced by Ultraviolet C and Radiation. J. Biol. Chem., 271, 31929-31936.
11. Yu, R., Shtil, A., Tan, T. H., Roninson, I. B. and Kong, A. N. T. (1996) Adriamycin activates c-jun N-terminal kinase in human leukemia cells: a relevance to apoptosis. Cancer Lett., 107, 73-81.
12. Seimiya, H., Mashima, T., Toho, M. and Tsuruo, T. (1997) c-Jun NH2-terminal Kinase-mediated Activation of Interleukin-1 Converting Enzyme/CED-3-like Protease during Anticancer Drug-induced Apoptosis J. Biol. Chem., 272, 4631-4636.
13. Śanchez-Ṕerez, I. and Perona, R. (1999) Lack of c-Jun activity increases survival to cisplatin. FEBS Lett., 453, 151-158.
14. Srivastava, R. K., Mi, Q.-S., Hardwick, J. M. and Longo, D. L. (1999) Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis. Proc. Natl. Acad. Sci. U.S.A., 96, 3775-3780.
15. Fan, M., Goodwin, M. E., Birrer, M. J. and Chambers, T. C. (2001) The c-Jun NH2-terminal Protein Kinase/AP-1 Pathway Is Required for Efficient Apoptosis Induced by Vinblastine. Cancer Res., 61, 4450-4458.
16. Mendelson, K. G., Contois, L. R., Tevosian, S. G., Davis, R. J. and Paulson, K. E. (1996) Independent regulation of JNK/p38 mitogen-activated protein kinases bymetabolic oxidative stress in the liver. Proc. Natl. Acad. Sci. U.S.A., 93, 12908-12913.
17. Niisato, N., Post, M., VanDriessche, W. and Marunaka, Y. (1999) Cell swelling activates stress-activated protein kinases, p38 MAP kinase and JNK, in renal epithelial A6 cells. Biochem. Biophys. Res. Commun., 266, 547-550.
18. Flamigni, F., Facchini, A., Stanic, I., Tantini, B., Bonavita, F. and Stefanelli, C. (2001) Control of survival of proliferating L1210 cells by soluble guanylate cyclase and p44/42 mitogen-activated protein kinase modulators. Biochem. Pharmacol., 62, 319-328.
19. Maria, A., Francisco, O., Lopez-Hernandez, J., Bayon, Y., Pfahl, M. and Piedrafita, F. J. (2001) Retinoid-related Molecules Induce Cytochrome c Release and Apoptosis through Activation of c-Jun NH2-Terminal Kinase/p38 Mitogen-activated Protein Kinases. Cancer Res., 61, 8504-8512.
20. Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J. and Greenberg, M. E. (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science, 270, 1326-1331.
21. Zhang, C. C. and Shapiro, D. J. (2000) Activation of the p38 mitogen-activated protein kinase pathway by estrogen or by 4-hydroxytamoxifen is coupled to estrogen receptor-induced apoptosis. J. Biol. Chem., 275, 479-486.
22. Yu, R., Mandlekar, S., Tan, T. H. and Kong, A. N. (2000) Activation of p38 and c-Jun N-terminal kinase pathways and induction of apoptosis by chelerythrine do not require inhibition of protein kinase C. J. Biol. Chem., 275, 9612-9619.
23. Assefa, Z., Vantieghem, A., Garmyn, M., Declercq, W., Vandenabeele, P., Vandenheede, J. R., Bouillon, R., Merlevede, W. and Agostinis, P. (2000) p38 mitogen-activated protein kinase regulates a novel, caspase-independent pathway for the mitochondrial cytochrome c release in ultraviolet B radiation-induced apoptosis. J. Biol. Chem., 275, 21416-21421.
24. Srivastava, R. K., Sollott, S. J., Khan, L., Hansford, R., Lakatta, E. G. and Longo, D. L. (1999) Bcl-2 and Bcl-X(L) block thapsigargin-induced nitric oxide generation, c-Jun NH(2)-terminal kinase activity, and apoptosis. Mol. Cell. Biol., 19, 5659-5674.
25. Zhuang, S., Demirs, J. T. and Kochevar, I. E. (2000) p38 mitogen-activated protein kinase mediates bid cleavage, mitochondrial dysfunction, and caspase-3 activation during apoptosis induced by singlet oxygen but not by hydrogen peroxide. J. Biol. Chem., 275, 25939-25948.
26. Yujiri, T., Sather, S., Fanger, R. S. and Johnson, G. L. (1998) Role of MEKK1 in Cell Survival and Activation of JNK and ERK Pathways Defined by Targeted Gene Disruption. Science, 282, 1911-1914.
27. Wisdom, R., Johnson, R. S. and Moore, C. (1999) c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J., 18, 188-197.
28. Hayakawa, J., Ohmichi, M., Kurachi, H., Ikegami, H., Kimura, A., Matsuoka, T., Jikihara, H., Mercola, D. and Murata, Y. (1999) Inhibition of Extracellular Signal-regulated Protein Kinase or c-Jun N-terminal Protein Kinase Cascade, Differentially Activated by Cisplatin, Sensitizes Human Ovarian Cancer Cell Line. J. Biol. Chem., 274, 31648-31654.
29. Davis, R. J. (2000) Signal transduction by the JNK group of MAP kinases. Cell, 103, 239-252.
30. MacKeigan, J. P., Collins, T. S. and Ting, J. P. (2000) MEK Inhibition Enhances Paclitaxel-induced Tumor Apoptosis. J. Biol. Chem., 275, 38953-38956.
31. Gupta, K., Kshirsagar, S., Li, W., Gui, L., Ramakrishnan, S., Gupta, P., Law, P. Y. and Hebbel, R. P. (1999) VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp. Cell Res., 247, 495-504.
32. Nishida, S., Fujii, Y., Yoshioka, S., Kikuichi, S., Tsubaki, M. and Irimajiri, K. (2003) A new bisphosphonate, YM529 induces apoptosis in HL60 cells by decreasing phosphorylation of single survival signal ERK. Life Sci., 73, 2655-2664.
33. Chen, Y. N., Cheng, C. C., Chen, J. C., Tsauer, W. and Hsu, S. L. (2003) Norcantharidin-induced apoptosis is via the extracellular signal-regulated kinase and c-Jun-NH2-terminal kinase signaling pathways in human hepatoma HepG2 cells. Br. J. Pharmacol., 140, 461-470.
34. Sundaram, S. G. and Milner, J. A. (1996) Diallyl disulfide induces apoptosis of human colon tumor cells. Carcinogenesis, 17, 669-673.
35. Hong, Y. S., Ham, Y. A., Choi, J. H. and Kim, J. (2000) Effects of allyl sulfur compounds and garlic extract on the expression of Bcl-2, Bax, and p53 in non small cell lung cancer cell lines. Exp. Mol. Med., 32, 127-134.
36. Kwon, K. B., Yoo, S. J., Ryu, D. G., Yang, J. Y., Rho, H. W., Kim, J. S., Park, J. W., Kim, H. R. and Park, B. H. (2002) Induction of apoptosis by diallyl disulfide through activation of caspase-3 in human leukemia HL-60 cells. Biochem. Pharmacol., 63, 41-47.
37. Nakagawa, H., Tsuta, K., Kiuchi, K., Senzaki, H., Tanaka, K. and Hioki, K. (2001) Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines. Carcinogenesis, 22, 891-897.
38. Bottone, F. G. Jr., Baek, S. J., Nixon, J. B. and Eling, T. E. (2002) Diallyl disulfide (DADS) induces the antitumorigenic NSAID-activated gene (NAG-1) by a p53-dependent mechanism in human colorectal HCT 116 cells. J. Nutr., 132, 773-778.
39. Cuadrado, A., Garcia-Fernandez, L. F., Gonzalez, L., Suarez, Y., Losada, A., Alcaide, V., Martinez, T., Fernandez-Sousa, J. M., Sanchez-Puelles, J. M. and Munoz, A. (2003) AplidinTM Induces Apoptosis in Human Cancer Cells via Glutathione Depletion and Sustained Activation of the Epidermal Growth Factor Receptor, Src, JNK, and p38 MAPK. J. Biol. Chem., 278, 241-250.
40. Lowe, S. W., Ruley, H. E., Jacks, T. and Housman, D. E. (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74, 957-967.
41. Fisher, D. E. (1994) Apoptosis in cancer therapy: crossing the threshold. Cell, 78, 539-542.
42. Thompson, C. B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1456-1462.
43. Thornberry, N. A. and Lazebnik, Y. (1998) Caspases: enemies within. Science, 281, 1312-1316.
44. Meinhardt, G., Wendtner, C. M. and Hallek, M. (1999) Molecular pathogenesis of chronic lymphocytic leukemia: factors and signaling pathways regulating cell growth and survival. J. Mol. Med., 77, 282-293.
45. Kolb, J. P. (2000) Mechanisms involved in the pro-and anti-apoptotic role of NO in human leukemia. Leukemia, 14, 1685-1694.
46. Hansen, M. B., Nielsen, S. E. and Berg, K. (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods, 119, 203-210.
47. Bates, R. C., Buret, A., van Helden, D. F., Horton, M. A. and Burns, G. F. (1994) Apoptosis induced by inhibition of intercellular contact. J. Cell. Biol., 12, 3-15.
48. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
49. Farrow, S. N. and Brown, R. (1996) New members of the Bcl-2 family and their protein partners. Curr. Opin. Genet. Dev., 6, 45-49.
50. Kroemer, G. (1997) The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med., 3, 614-620.
51. Knowles, L. M. and Milner, J. A. (2003) Diallyl disulfide induces ERK phosphorylation and alters gene expression profiles in human colon tumor cells. J. Nutr., 133, 2901-2906.
52. Knowles, L. M. and Milner, J. A. (1998) Depressed p34cdc2 kinase activity and G2/M phase arrest induced by diallyl disulfide in HCT-15 cells. Nutr. Cancer, 30, 169-174.